This filing contains only routine board and leadership changes with no financial or operational catalysts. Monitor upcoming quarterly results for any strategic shifts under the new chair/CEO structure.
Price Chart
Executive Summary
Xeris Biopharma announced routine board governance changes: CEO John Shannon was appointed Chair of the Board, Marla Persky transitioned to Lead Independent Director, and Nerissa Kreher, M.D., was added as an independent director. The board expanded from seven to eight members. No financial data or operational updates were provided.
Key Facts
- Board expanded from 7 to 8 members with the appointment of Nerissa Kreher, M.D., effective July 1, 2026
- CEO John Shannon appointed Chair of the Board, effective July 1, 2026
- Marla Persky designated as Lead Independent Director, effective July 1, 2026
- Dr. Kreher received an initial equity award with aggregate grant date fair value of approximately $450,000
- Dr. Kreher is independent under Nasdaq listing standards and has extensive biotech CMO experience
Financial Impact
No financial impact; routine governance changes with no material financial data disclosed
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001867096-26-000048 |
| Exhibit: exh991boardappointmentpres.htm | 0001867096-26-000048 |
| Document: 0001867096-26-000048-index-headers.html | 0001867096-26-000048 |
| Document: 0001867096-26-000048-index.html | 0001867096-26-000048 |
| Document: 0001867096-26-000048.txt | 0001867096-26-000048 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | 8-K | $7.71 $7.78 | ▲ +0.91% | ▲ +1.56% | $9.08 (+17.77%) |
Sep 1, 2026 4w ago | Insider Cluster | $8.58 $7.67 | ▼ −10.61% | ▼ −9.65% | $9.08 (+5.83%) |
Aug 6, 2026 8w ago | 8-K | $7.36 $8.33 | ▲ +13.18% | ▲ +11.97% | $9.08 (+23.37%) |
Aug 4, 2026 8w ago | Insider Cluster | $8.19 $8.39 | ▲ +2.44% | ▲ +2.54% | $9.08 (+10.87%) |
Jul 7, 2026 12w ago | Insider Cluster | $8.94 $8.28 | ▲ +7.38% | ▲ +7.93% | $9.08 (−1.57%) |
Jul 2, 2026 13w ago | 3 | $8.28 $8.62 | ▲ +4.11% | ▲ +3.18% | $9.08 (+9.66%) |
Jul 2, 2026 13w ago | Insider Cluster | $8.28 $8.62 | ▲ +4.11% | ▲ +3.18% | $9.08 (+9.66%) |
Jun 30, 2026 13w ago | 8-K | $8.00 $8.94 | ▲ +11.75% | ▲ +11.49% | $9.08 (+13.50%) |
Jun 12, 2026 16w ago | Institutional Cluster | $6.79 $6.95 | ▲ +2.36% | ▲ +1.68% | $9.08 (+33.73%) |
Jun 5, 2026 16w ago | Insider Cluster | $6.24 $6.88 | ▲ +10.26% | ▲ +8.14% | $9.08 (+45.51%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access